DE808846T1 - Peptide, die mit Antikörpern reagieren, die den Fortschritt der HIV-Erkrankung markieren - Google Patents

Peptide, die mit Antikörpern reagieren, die den Fortschritt der HIV-Erkrankung markieren

Info

Publication number
DE808846T1
DE808846T1 DE0808846T DE97107975T DE808846T1 DE 808846 T1 DE808846 T1 DE 808846T1 DE 0808846 T DE0808846 T DE 0808846T DE 97107975 T DE97107975 T DE 97107975T DE 808846 T1 DE808846 T1 DE 808846T1
Authority
DE
Germany
Prior art keywords
peptides
antibodies
react
progress
mark
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE0808846T
Other languages
English (en)
Inventor
Veljko Veljkovic
Radmila Metlas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diapharm Ltd
Original Assignee
Diapharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9610673A external-priority patent/GB2313376A/en
Priority claimed from GB9623340A external-priority patent/GB2319252A/en
Application filed by Diapharm Ltd filed Critical Diapharm Ltd
Publication of DE808846T1 publication Critical patent/DE808846T1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE0808846T 1996-05-22 1997-05-16 Peptide, die mit Antikörpern reagieren, die den Fortschritt der HIV-Erkrankung markieren Pending DE808846T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9610673A GB2313376A (en) 1996-05-22 1996-05-22 Polypeptide immunologically cross-reactive with NTM peptide and with vasoactive intestinal peptide (VIP)
GB9623340A GB2319252A (en) 1996-11-08 1996-11-08 Polypeptides involved in the interaction of HIV gp120 with the fusin, and the CC-CKR-5 co-receptors thereof

Publications (1)

Publication Number Publication Date
DE808846T1 true DE808846T1 (de) 1998-06-25

Family

ID=26309377

Family Applications (1)

Application Number Title Priority Date Filing Date
DE0808846T Pending DE808846T1 (de) 1996-05-22 1997-05-16 Peptide, die mit Antikörpern reagieren, die den Fortschritt der HIV-Erkrankung markieren

Country Status (7)

Country Link
US (1) US20010007017A1 (de)
EP (1) EP0808846A3 (de)
JP (1) JPH10237100A (de)
CA (1) CA2205077A1 (de)
DE (1) DE808846T1 (de)
ES (1) ES2113333T1 (de)
GR (1) GR980300031T1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103412490B (zh) * 2013-08-14 2015-09-16 山东大学 用于多机器人动态路径规划的多克隆人工免疫网络算法
US20220205030A1 (en) * 2019-02-11 2022-06-30 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Vaccine-induced gene signatures correlating with protection against hiv and siv infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989005821A1 (en) * 1987-12-21 1989-06-29 Arch Development Corporation Hiv-related antigens and antibodies
FR2677364A1 (fr) * 1991-06-05 1992-12-11 Pasteur Institut Sequences peptidiques de la glycoproteine externe d'enveloppe du retrovirus hiv-1.
FR2687404B1 (fr) * 1992-02-19 1994-05-20 Centre Nal Recherc Scientifique Peptides immunologiquement apparentes aux proteines d'un agent viral et leurs applications biologiques.

Also Published As

Publication number Publication date
JPH10237100A (ja) 1998-09-08
GR980300031T1 (en) 1998-05-29
EP0808846A2 (de) 1997-11-26
US20010007017A1 (en) 2001-07-05
EP0808846A3 (de) 1998-08-26
ES2113333T1 (es) 1998-05-01
CA2205077A1 (en) 1997-11-22

Similar Documents

Publication Publication Date Title
DE69739219D1 (de) Peptide und zusammensetzungen, die an den thrombopoietin-rezeptor binden
MX9801863A (es) Microemulsion.
TR199700358A3 (tr) Interferon birlesimler.
NL1004305A1 (nl) Wandelstok.
DE570357T1 (de) Peptide, die Antikörper induzieren, die genetisch divergierende HIV-1 Isolationen neutralisieren.
TR199802624A3 (tr) Yeni farmasötik.
FI952444A0 (fi) Pneumokokin pintaproteiinin A epitooppiset alueet
ATE348836T1 (de) Neue 3,6-hemiketale der 9a-azalidklasse
TR199500915A2 (tr) Peptidler.
IT1303546B1 (it) Cerniera lampo.
TR199800604A3 (tr) Anti-fas antikorlari.
EA200000208A1 (ru) Иммуномодулятор с антимикробной и антимикобактериальной активностью, способ его получения и лекарственный препарат для лечения микобактериозов, хронических неспецифических заболеваний легких, заболеваний, передающихся половым путем, и иммунодефицита на их основе
DE808846T1 (de) Peptide, die mit Antikörpern reagieren, die den Fortschritt der HIV-Erkrankung markieren
TR199501328A2 (tr) Alzheimer peptidi.
NO980375D0 (no) Humant MP52 Arg protein
DE29502101U1 (de) Verbindung von flächigen, miteinander fluchtenden Planteilen
ID20352A (id) Bahan herbisida 3,5-difluoropiridin
DK0866800T3 (da) Antineoplastiske peptider
NO20002862L (no) Forbedret stempelring
MXPA01010743A (es) Un ligando de la proteina "beacon".
DZ2803A1 (fr) Polypeptide de la protéine c humaine.
ES1041026Y (es) Vibrador terapeutico.
ITGE960040A0 (it) Pentapeptide.
ATA98792A (de) Peptide, die antikörper binden
ITBO970564A0 (it) Cravatta.